Clinical Trial Update: Trastuzumab Deruxtecan in Advanced Breast Cancer

View source ↗

Summary

A clinical trial update indicates that a study evaluating trastuzumab deruxtecan for advanced breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: Wenjin Yin | Conditions: Advanced Breast Cancer | Status: RECRUITING